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Abstract
In order to control microbial resistance against commonly used antibiotics, it is indis-
pensable to develop novel and efficient antimicrobial agents. For this purpose, metallic 
nanoparticles (mainly inorganic) with their antimicrobial activites represent an effective 
solution for this global problem. However, synthesis of nanoparticles involves the use of 
expensive, poisonous and dangerous chemicals responsible for different biological and 
environmental hazards. This fact increases the necessity of developing environment-
friendly procedure by means of green synthesis (using plants) and extra-biological meth-
ods (using microbes such as bacteria and fungi). More recently, metallic nanoparticles, 
derived from fungal sources, have demonstrated their potential not only as a new-gener-
ation antimicrobial agents but also as anticancer agents. Therefore, this chapter is aimed 
to explore the various nanoparticles producing fungi with ultimate objective of eluci-
dating the possible (i) mechanism of biosynthesis of metallic NPs by various fungi and 
(ii) mode of action of these mycosynthesized NPs on bacterial cell. This chapter would 
certainly increase our knowledge about interaction of nanoparticles with bacterial cell for 
their use in health biotechnology.
Keywords: nanoparticles, silver, myconanosynthesis, fungi, cancer, 
antibacterial activities
1. Introduction
In the field of nanotechnology and nanomaterial, more specifically, nanoparticles are extremely 
important because of their unique optical, physicochemical, and biological facets. Though their 
biological synthesis is still at early stages and many material scientists around the globe are 
working on the production of nanoparticles from different sources including plants, animals, 
microbes, and metallic compounds like gold, silver, platinum, etc. Various studies on biosyn-
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thesis of nanoparticles have been carried out using a wide array of microorganisms such as 
algae, bacteria, actinomycetes, fungi, yeasts, and viruses [1, 2]. Among the many possible bio-
resources, biologically active products from fungi and yeast represent excellent scaffolds for 
this purpose. Since fungi and yeast are very effective secretors of extracellular enzymes and 
number of species grow fast and therefore culturing and keeping them in the laboratory is 
very simple [3]. They are able to produce metal nanoparticles and nanostructure via reducing 
enzyme extracellularly [3, 4]. Not only the harvesting of extracellularly synthesized nanopar-
ticles from fungi is easy and inexpensive [2, 5], they can also be manipulated by controlling 
the pH, temperature, substrate concentration (metal ions), and reaction time [6, 7]. Therefore, 
the biosynthesis could be ideally used for large-scale production of nanoparticles for several 
industrial applications [3]. Importantly, fungi have also secreted fairly large amount of pro-
teins and secondary metabolites extracellularly, and hence, the fungal biomass could reduce 
the metal ions more easily leading to the rapid formation of nanoparticles [8]. Because of 
these advances, the myco-based extracellular synthesis method is often considered as a better 
resource for higher productivity of nanoparticles [4].
On the other hand, increasing incidence of microbial resistance to clinically approved classes 
of antibiotics has emerged in recent years and is a major health problem, requiring to develop 
novel and effective antimicrobial agents [4, 9–11]. Owing to their antibacterial activities, metal-
lic nanoparticles (mainly silver and gold) represent a novel and an effective solution for over-
coming bacterial resistance. In general, nanoparticles are divided into two groups, i.e., organic 
and inorganic, where the later one being significant biomedical agents [12]. These silver and 
gold nanoparticles, derived from microbial sources, have demonstrated their potential not 
only as a new generation antimicrobial [13] agents against a broad spectrum of Gram-positive 
and Gram-negative bacteria including multidrug-resistant human pathogens, but also as anti-
cancer agents [3]. They have also significantly enhanced the bactericidal activity when used in 
combination with standard antibiotics [14]. However, synthesis of nanoparticles involves the 
use of expensive, poisonous, and dangerous chemicals responsible for different biological and 
environmental hazards. This fact increases the necessity of developing environment-friendly 
procedure by means of green synthesis (using plants) and extra biological methods (using 
microbes such as bacteria and fungi) [15]. Therefore, as a part of our continuing search to 
identify microorganisms with the potential to synthesize nanoparticles with amazing biologi-
cal properties, interest has spurred on microbes [11], especially fungi. Indeed a few fungal 
species around the globe have been reported to secrete nanoparticles. Therefore, the present 
chapter is aimed to provide an overview of nanoparticles producing fungi, with the ultimate 
objective of producing effective antimicrobial agents.
2. Biosynthesis of nanoparticles by fungi
In the last decade, biomineralization has been developed as an emerging and attractive tech-
nique for the synthesis of metallic nanoparticles. In which microbial cells are preferably being 
used for the synthesis of nanosized material involving the oxidation/reduction of metallic 
ions (like silver, gold, platinum, etc.) giving rise to nanostructures and nanoparticles [16]. 
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This green synthesis of metallic nanoparticles undergo three necessary steps (Figure 1) 
that are (i) choice of appropriate solvent medium, (ii) choice of appropriate reducing agent 
 (environment friendly), and (iii) stabilizing agents or substances for silver nanoparticles sta-
bility [17]. Generally, this reduction is carried out by means of microbial enzymes (Figure 1), 
present in microbes, and considered to be responsible for synthesis of nanoparticles by those 
 organisms [18, 19].
For this purpose, various fungi have been used as novel and assuring resources for manufac-
turing of nanoparticles extracellularly as well as intracellularly, such as Aspergillus, Pencillium, 
Fusarium, and Verticillium. Though synthesis of metallic nanoparticles (NPs) having defined 
size, shape, and composition by fungi are major challenges in this field [20, 21]. In general, 
fungal enzymes with reducing capabilities are mostly responsible for reduction of metal ions 
(Figure 1) to their corresponding nanoparticle(s) as described earlier [22]. We will discuss 
biosynthesis of NPs from various fungi one by one.
2.1. Biosynthesis of nanoparticles by Fusarium
Several fungal strains belonging to genera Fusarium have been studied for the production of 
metallic nanoparticles. Dias and coworkers [23] have screened different Fusarium species to 
be used as potential candidate(s) for biosynthesis of silver NPs. They have obtained the tiniest 
size silver-nanoparticles (Ag-NPs) by Fusarium oxysporum through extracellular reduction of 
Ag+ ions in aqueous medium [24–26]. Generally, two methods were used to evaluate the syn-
thesis of silver nanoparticles by Fusarium species involving (i) silver reduction method that 
involve the fungus biomass in conical flask containing AgNO
3
 solution and distilled water. In 
other method, fungal filtrate were obtained by keeping fungal biomass in distilled water for 
72 h at 28°C that was further challenged with AgNO
3
 solution (10−3 M). In this study, several 
strains of Fusarium oxysporum were exposed to AgNO
3
 solution (10−3 M) leading to the reduc-
tion of silver ions and thereby formation of silver hydrosol. The silver nanoparticles produced 
Figure 1. Intracellular and extracellular biosynthesis of metallic nanoparticles (NPs) by fungi.
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were in range of 20–50 nm in diameter as a result of nitrate-dependent reductase and shuttle 
quinone extracellular activities [27]. Similar study was also performed using similar fungal 
species, i.e., Fusarium oxysporum by Mohammadian et al. [28] who observed that synthesis of 
silver nanoparticles was extremely rapid even at ambient conditions that can compete with 
chemical synthesis, highly stable even for months in darkness (without light). To date, various 
Fusarium species have been reported to produce metallic nanoparticles for silver [13, 29–33], 
zirconia [34, 35], platinum NPs intra- and extracellularly [13, 32].
2.2. Biosynthesis of nanoparticles by Penicillium
Certain filamentous fungi such as Penicillium were also investigated for the synthesis of 
metallic nanoparticles. For this purpose, various studies have been carried out using different 
species of Penicillium including (but not limited to) P. brevicompactum [36], P. fellutanum [37], 
Penicillium sp. [38], P. citrinum [39], P. fellutanum [36], and P. purpurogenum [40]. Nanoparticles 
produced by Penicillium spp. are relatively more stable at neutral pH (>8.0) due to repul-
sion as they possess zeta potential (negative) [41]. In another study, where P. fellutanum was 
challenged with silver ions, it could reduce metallic ions in 10 min, when it came in contact 
with fungus filtrate [37]. Presence of single protein having molecular weight of about 70 kDa 
was observed in gel electrophoreses. The authors supposed that nitrate reductase enzymes 
could possibly be responsible for the reduction of silver ions (Figure 1). In addition, the whole 
reduction process could be manipulated by controlling concentration and exposure time to 
Ag+ ions, pH, and temperature [37, 42]. Although exact mechanism commanding the Ag+ ions 
reduction is not yet comprehended, however, authors have assumed that reducing agents are 
secreted by fungi as a response to stress posed by metal ions [40, 42]. Moreover, these silver 
NPs were uniformly distributed over fungal mycelium (Penicillium sp.) suggesting that silver 
NPs were bound with cells of fungal surface. This was further confirmed by FTIR spectros-
copy. In which it was described that both carbonyl groups from amino acid residues and pep-
tides of protein(s) had strong affinities for binding with Ag+ ions in order to form protective 
covering around silver NPs to avoid their clustering [36].
2.3. Biosynthesis of nanoparticles by Aspergillus
Biosynthesis of NPs from species belonging to genera Aspergillus is more desirable and eco-
nomically important due to its occurrence in natural habitat along with easy culturing on 
growth media [43]. In the same study, five species belonging to genus Aspergillus, i.e., A. 
nidulans, A. flavus, A. terreus, A. fumigatus, and A. niger, were synthesized, in which A. terreus 
was proved to be more potent NPs producer among all and was further investigated. It was 
observed that silver NPs were highly stable even after 4 months due to the presence of stabi-
lizing agents mostly “protein” that would allow functionalizing the NPs with other biological 
molecules [44]. Their proper functionalizing is an important factor for appropriate antimicro-
bial activities of these metallic nanoparticles (NPs). In addition, FTIR analyses revealed amide 
linkages between amino acid residues and NPs. Most active functional groups involved in 
the reduction of silver ions being the hydroxyl, carboxyl, and carbonyl groups [10, 43, 45–48]. 
Depending on the biological system used, different sizes and shapes of NPs had been reported 
ranging from 5 to 45 nm [49] with spherical NPs being the dominant [43].
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In another study, AgNP were synthesized using aqueous supernatant of A. niger. Synthesized 
silver NPs were mainly round shape ranging in size from 1 to 20 nm [50]. Various studies have 
shown the mycosynthesis of silver nanoparticles extracellularly through the reduction of Ag+ 
ions using different species belonging to genus Aspergillus, such as A. niger [51], A. flavus [52], 
A. terreus [53], A. clavatus [54, 55], A. fumigatus [56], and A. tamari [57]. Majority of these NPs 
were in the range of 1–20 nm with spherical shape.
2.4. Biosynthesis of nanoparticles by other fungi
Various other fungal genera were also exploited for the synthesis of silver nanoparticles. 
Metallic NPs can be synthesized using fungal biomass and cell-free supernatant. Among 
eukaryotes, yeast was repeatedly explored for the formation of metallic nanoparticles. Since 
then, many studies were carried out in order to evaluate the fungal potential as potent pro-
ducer of silver nanoparticles. For example, cadmium nanoparticles (CdS) were synthesized 
intracellularly by Schizosaccharomyces pombe and Candida glabrata when challenged with Cd+2 
ions [42, 58–60]. The authors proposed that these NPs were covered with phytochelatin [42]. 
Similarly, other studies have also reported the biosynthesis of metallic nanoparticles using 
fungi such as Toluropsis sp. for Pb nanocrystals [60] and for Cu NPs using Humicola sp. [61]. 
Formation of gold nanoparticles was described in yeast Yarrowia lipolytica NCIM 3589 that 
were highly stable [62, 63]. As described earlier, shape and size of NPs mainly rely on the reac-
tion conditions like temperature, pH, metal concentrations, and reaction time [16].
However, first example of intracellular mycosynthesis of silver and gold NPs was demon-
strated using Verticillium sp. biomass, challenged with aqueous silver ions [64, 65]. Although 
the mechanism of biosynthesis was not clearly understood, however, it was assumed that 
metal ions (silver or gold) either (i) adsorbed on cell surface or enter into cytoplasm via diffu-
sion. In both cases, these metallic ions were reduced by enzymes present on the cellular mem-
brane and/or cytoplasm [64, 65]. Similarly, different species belonging to genus Trichoderma 
and Phoma were also screened for the synthesis of metallic NPs with dimensions ranging from 
8 to 60 nm [66, 67] for the selection of potential species as a new synthesizer of silver NPs.
3. Application of mycosynthesized nanoparticles in biomedics
Mycosynthesized nanoparticles are of extreme importance because of their unique optical, 
physicochemical and biological facets. These nanosized particles are continuously being used 
in different fields including electronics [68], catalytic processes [69], optical devices [12], sen-
sor technology [70], biological labeling [71], and may suppress the expression of proteins 
associated with adenosine triphosphate production [72], agriculture, pharmacology, and 
environmental monitoring [73]. More recently they are being used as novel antimicrobial and 
anticancer agents [61, 74–82]. Antimicrobial mediators can be either synthetic and/or partially 
modified natural compounds [82, 83]. Type of antimicrobials agent(s) may vary according to 
targeted pathogens, e.g., antibacterial (for bacteria), antifungal (for fungi), and antiviral (for 
virus). Similarly, their mechanism of action on microbial cell varies according to the nature of 
the antimicrobial agents and pathogens. Main targets for antimicrobial compounds could be 
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cell wall (cephalosporins, bacitracin, penicillins, etc.) and protein synthesis, DNA replication 
(tetracyclines, chloramphenicol, lincosamides, etc.) and metabolism (intermediary) processes 
(valinomycin, Gramicidin A, etc.), and DNA-synthesis (rifampicin, sulfonamides, quinolones, 
etc.) as described in Figure 2 [82]. However, abusive use of antimicrobials against various 
pathogens has evolved into the development of highly adapted and resistant microbes. In 
addition, these resistant microbes are now being spread globally, challenging the treatment to 
common infections, and posing significant health threat around the globe. Multidrug-resistant 
bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 
enterococci, have emerged as a symbol of global health hazard during the last decade.
4. Antibacterial activity of mycosynthesized nanoparticles
Uses of nanoparticles in medicine, particularly in the treatment of bacterial infections, have 
proved them as effective and novel healing tools against microorganisms. Though for cen-
turies, natural silver has already been considered as one of the most safe and nontoxic inor-
ganic antimicrobial agents [84]. Even silver nanoparticles have also exhibited broad-spectrum 
antimicrobial properties due to its unique physiochemical and biological characteristics [85]. 
Recently, silver NPs have shown excellent antimicrobial efficacy against certain bacterial 
pathogens such as Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Staphylococcus epider-
mis, Leuconostoc mesenteroides, Klebsiella pneumonia, and K. mobilis [84]. Reason for their higher 
antimicrobial efficacy lies with higher surface area-to-volume ratio of AgNPs that enables 
Figure 2. Possible mechanism of action of silver NPs on bacterial cell.
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them to bring large portion of Ag atoms in contact with the environment (i.e., microbial 
cell). However, mechanism of antibacterial activity of silver NPs has not been completely 
 understood [84–88].
Silver nanoparticles have shown inhibitory effect on growth in both Gram-positive and 
Gram-negative bacteria. As described earlier, larger surface area of silver nanoparticles are 
believed to be key player in interaction with bacterial cell wall and would have resulted 
in more antibacterial activity. Although mechanism of action of silver NPs on bacterial 
cell is debatable; however, assumed mechanism include (i) adherence of AgNPs with bac-
terial cell wall causing membrane lysis, ultimately releasing cellular contents leading to 
destruction of cell structure and death [89–91], (ii) interaction of Ag ions with free thiol 
groups (−SH) and disulfide bridges (-S-S-) of cellular enzymes and membrane of bacteria 
to downregulate or inactivate the cellular protein synthesis by interfering the translation 
[72, 91, 92], (iii) blocking DNA replication [93], and (iv) inhibition of signal transduction by 
dephosphorylation of peptide substrates on tyrosine residues (Figure 2) [91]. Furthermore, 
inhibitory effect of AgNPs varied for different bacterium, e.g., Gram-positive bacteria 
were more susceptible to silver nanoparticles as compared to Gram-negative one [84]. The 
authors have found larger inhibition zone (diameter) in case of S. aureus than that of E. coli 
suggesting that variation in inhibitory response could be attributed to difference in cell wall 
and capsular composition, S-layer thickness, cellular metabolism and its byproducts, or a 
combination of these [84].
5. Anticancer potential of mycosynthesized nanoparticles
About 10 million people are being diagnosed with cancer annually, with higher mortality rate 
around the globe [94]. It is generally developed due to disturbance in various physiological 
processes like cell signaling and apoptosis [94]. In this disease, continuous growth of cancer 
cell due to resistance to wide range of anticancer agents has become the major challenge to 
pharmacist while treating the disease [95, 96]. Certain factors such as insufficient drug con-
centrations approaching tumor cells, intolerable cytotoxicity, nonspecific distribution of anti-
cancer agents, and poor monitoring of drug responses particularly in developing countries 
has made cancer incurable [97, 98].
Recently, the emerging field of nano-biomedicine has highlighted the possibility of metallic 
NPs to be used for disease diagnosis and cancer treatment in humans [94]. Among various 
metallic NPs, silver nanoparticles are considered as novel and promising nanoproducts that 
can be exploited in the field of nanomedicine due to their unique and distinctive properties. 
Although antibacterial activity of Ag nanoparticles is well established, however, their anti-
cancer activities have recently been reported against various cancerous cell lines [94, 99], and 
mechanism of action of AgNPs are still under evaluation and there are many ambiguities that 
should be addressed in future research.
It is well established that silver nanoparticles when interacting with various biomolecules, such 
as DNA, proteins, and carbohydrates, may cause cell death due to apoptosis or  cytotoxicity 
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probably through reactive oxygen species (ROS) [32, 94]. Various factors influencing cytotox-
icity of silver nanoparticles include dosage, contact time, and size of particles. For example, 
in case of human epidermoid larynx (Hep-2) cell line, cellular damage was dose dependent, 
causing cell death through ROS [96, 100, 101]. In another study, silver nanoparticles have 
shown cytotoxic effect through loss of mitochondrial integrity and activation of caspase-cas-
cade exhibiting the apoptotic effect leading to cell death. In a recent study, AgNPs from plant 
extract, inhibited proliferation of human colon cancer cell line HCT15 while suppressing its 
cellular growth, inhibiting the G
0
/G
1
-phase, interfering DNA synthesis, and ultimately caus-
ing cell death through apoptosis [102]. Another important criterion for efficient anticancer 
drug is its ability to induce apoptosis cancer cell since they generally escape from programed 
cell death [103]. In recent studies it has been shown that silver nanoparticles possess this 
property [104]. The authors have treated the tumor-bearing mice (in vivo) with AgNPs that 
have reduced the tumor weight and increased its life span. The hematologic studies revealed 
reduced white blood cell (WBC) and platelet count in diseased mice as compared to control 
(disease free) suggesting that silver NPs were relatively nontoxic and did not produce any 
change in hematologic parameters and controlled the WBC that were important constituent 
of immune system of body. The authors further proposed that silver NPs could be used as 
potent therapeutic agents in order to delay the tumor progression in DLA cell lines through 
growth suppression and cytotoxic effects that increased vascular permeability leading to 
tumor cell death that could be linked to caspase enzyme activation. However, mode of action 
of silver NPs due to which they inhibit cell proliferation and viability causing tumor cell death 
has not been clearly understood.
6. Conclusion
The use of nanoparticles in the field of medicine is proving to be a novel and promising 
technique in order to treat various infections. Among various NPs, silver NPs have proved 
to possess therapeutic alternative that can be exploited in diagnostic and treatment of certain 
bacterial infections and cancer. To date, various fungi have been reported to biosynthesize the 
silver nanoparticles. A few among them have been evaluated for the treatment of infection(s) 
caused by bacterial pathogens providing evidence for their potential role as a new generation 
antimicrobial agents against a broad spectrum of Gram-positive and Gram-negative bacteria 
including multidrug-resistant human pathogens. In addition, monodispersed silver NPs can 
be synthesized by controlling various parameters (such as pH, temperature, etc.) to avoid 
toxic effects on human cells. Furthermore, biosynthesized silver NPs have successfully exhib-
ited the anticancer activities against different cancer cell lines through inhibiting cell progres-
sion (cell proliferation), ROS formation, blockage of DNA synthesis, and apoptosis. However, 
further research work is required to understand possible mechanism of action of antibacte-
rial and anticancer activities of silver NPs on microbial cell. Various factors (physiochemical 
and biological) affecting bioavailability, biocompatibility, and cellular toxicity of silver NPs 
at molecular level should also be addressed in future research that will open new insight for 
their application alone or in combination with other bioactive agents to control and treat the 
microbial infections and cancer.
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